Company Worth Watching: Harvard Start-up Platelet Biogenesis Creates Platelets from Stem Cells

By | July 24th, 2017|0 Comments

Platelets are the band aids of the bloodstream, and Platelet BioGenesis is disrupting the way in which humans heal. Platelet BioGenesis, a Larta NIH-CAP graduate, is a pre-clinical is a [...]

Company Worth Watching: Aptimmune Biologics

By | June 30th, 2017|0 Comments

In June, the World Pork Expo kicked off in Des Moines, Iowa, and with it came a revolutionary unveiling from one of our Larta CAP companies: Aptimmune Biologics. Aptimmune launched [...]

Ag-tech is attracting women-led innovations, and they’re disrupting

By | June 30th, 2017|0 Comments

Uber CEO Travis Kalanick's recent resignation over inappropriate remarks about women raises questions of gender diversity and success in tech startups. A culture of gender diversity and its importance to [...]

Ag Innovation Showcase announces 18 early-stage companies to present in St. Louis

By | June 28th, 2017|0 Comments

The 18 companies that will take to the main stage at the 9th annual Ag Innovation Showcase (“the Showcase”) have been announced by event organizers, Larta Institute, Donald Danforth Plant [...]

Scientific American runs Rohit Shukla’s blog piece on the federal budget for science and what that means for entrepreneurs

By | June 28th, 2017|0 Comments

"Science and technology innovation is an engine of our competitiveness, and small business is its driver. The President’s “skinny budget” threatens this. It proposes suggests radical cuts to NIH and [...]

LA BioMed Launches Commercialization Accelerator Program™ Powered by Larta Institute

By | June 16th, 2017|0 Comments

LOS ANGELES – (June 17, 2017) – LA BioMed is launching a Commercialization Accelerator Program™ (CAP), designed and implemented by Larta Institute, that will offer LA BioMed’s early stage bioscience [...]

In search of a winner: the hidden costs of FDA deregulation

By | May 30th, 2017|2 Comments

For years politicians, and especially congressional Republicans, have argued for fewer regulations on industry, asserting that a reduction in restrictions would increase the pace of business deals, which would in [...]